Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

Is Kenvue Stock Outperforming the S&P 500?

With a market cap of $43.6 billion, Kenvue Inc. (KVUE) operates as a consumer health company in the United States and internationally. The Skillman, New Jersey-based company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health.

Companies valued at more than $10 billion or more are generally considered “large-cap stocks”, and KVUE fits this criterion perfectly. The company benefits from a large portfolio of consumer health offerings under reputable brands including Tylenol, Motrin, Benadryl, Nicorette, Listerine, Band-Aid, and Stayfree.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.